Sanchez: Can Sen. McCaskill stem the opioid epidemic? She’s trying

If you want to understand America’s opioid epidemic, start with an autopsy.

Sarah Fuller died March 25, 2016. She was 32, suffering from chronic head and neck pain due to two car accidents. The cause of her death was allegedly an overdose of Subsys, a highly addictive spray medication developed to ease intense pain associated with cancer — debilitating pain that other drugs can’t relieve. It contains fentanyl, which is often said to be 50 times as powerful as heroin.

Fuller did not have cancer. According to a congressional report made public this week by Sen. Claire McCaskill, a Democrat from Missouri, Fuller never should have been prescribed the drug, as she didn’t qualify for it medically. The devious and possibly illegal way that she did receive it is the subject of McCaskill’s report.

“Basically, you know, they set her up to die,” the deceased woman’s mother, Deborah Fuller, told The Philadelphia Daily News.

A drug sales representative with the Arizona-based Insys pretended to be an employee of Fuller’s doctor’s office. She placed a call and stretched the truth, implying that Fuller needed Subsys. It’s all on tape and was played at the release of the report this week. The rep’s motivation can be inferred from the fact that Fuller’s medicine cost as much as $24,000 a month over a 14-month treatment period.

The title of the report is a mouthful: “Fueling an Epidemic: Insys Therapeutics and the Systemic Manipulation of Prior Authorization.” The key word is “systemic.”

Understanding the opiate crisis requires unraveling a system in which many players participate and benefit: drug company shareholders, sales representatives, doctors and other intermediaries who OK prescriptions, among others.

The FDA approved Subsys in 2012, and soon it was generating sensational profits. According to the report, revenues and profits soared, and the “value of company stock increased 296 percent between 2013 and 2016.” It’s highly likely that a culture of chasing sales goals helped form the dynamics behind what is alleged to have happened to Fuller.

According to McCaskill’s report, “Neither the Insys sales representative nor (Fuller’s doctor) informed Sarah or her father that Subsys was fentanyl and that it was only approved and indicated for patients that were experiencing breakthrough cancer pain from malignant cancer.” This would have been important to know, as Fuller’s parents had disclosed to her doctor that she had previously overcome addiction to narcotic pain medication.

McCaskill is approaching the opioid epidemic with the skills of a county prosecutor, her prior calling. Her office is investigating five manufacturers and distributors of these highly addictive drugs, delving into the practices of insurers to approve such drugs.

Too often, people who overdose are seen as weak and somehow deserving of their fate for having let themselves get addicted. This congressional report pokes a very big hole in that fallacy.

Insys insists that this is all past tense, claiming that long-gone executives were responsible. The firm asserts that it has cleaned its own house and established compliance programs while fully cooperating with federal agents.

Sorry, there are no morality medals for acting after being caught.

This is just one company and the story of one victim. There are many more — each with a heartbreaking tale, each a part of this unfolding saga of addiction sweeping America.

Reader Comments ...

Next Up in Opinion

From print to e-books, sadly but inevitably

I’ve got cards from four libraries but haven’t checked a book out in a year. Which is strange, because I came from a printing/publishing family, worked part-time in school libraries during college, and can read. What happened? One hyphenated pseudo-word, “e-books.” I still like the look and feel of print books and the smell...
Cruelty, incompetence and lies

Graham-Cassidy, the health bill the Senate may vote on next week, is stunningly cruel. It’s also incompetently drafted: The bill’s sponsors clearly had no idea what they were doing when they put it together. Furthermore, their efforts to sell the bill involve obvious, blatant lies. Nonetheless, the bill could pass. The Affordable Care Act...
Politicking in Ohio is about deals, not ideals

In about 60 weeks, Ohio will elect its next governor. Between now and then, you’ll hear a lot about programs, platforms – and “philosophy.” In terms of Ohio politics, those big words mean exactly nothing. Politicking in Ohio isn’t about ideals. It’s about deals: Who gets what, and how, and when. The successful candidate...
Opinion: The steep cost of cheap speech

WASHINGTON — At this shank end of a summer that a calmer America someday will remember with embarrassment, you must remember this: In the population of 325 million, a small sliver crouches on the wilder shores of politics, another sliver lives in the dark forest of mental disorder, and there is a substantial overlap between these slivers. At...
Working from the ground up to get rid of ‘food deserts’
Working from the ground up to get rid of ‘food deserts’

Q: What is the Gem City Market project all about? Klein: The Gem City Market will be a vibrant worker- and community-owned full-service grocery store on lower Salem Avenue, just across the river from downtown Dayton. The incubation of the market has been a community-driven effort aimed at addressing the needs of Daytonians who live in what the United...
More Stories